popular cancer topics
A study by the Ontario Institute for Cancer Research reveals how smoking triggers cancer development. The research found that smoking initiates “stop-gain” mutations in the DNA, leading to the inhibition of protective proteins that regulate cell growth. This disruption allows abnormal cells to proliferate unchecked, potentially promoting cancer onset. The study also demonstrated a strong correlation between smoking duration, intensity, and mutation occurrence. These findings improve understanding of the molecular mechanisms underlying smoking-induced cancer.
An exciting study reveals that artificial intelligence (AI) has exhibited an ability almost twice as effective as conventional methods in assessing the aggressiveness of a rare cancer through scans. The AI, discerning details imperceptible to the human eye, demonstrated 82% accuracy in grading cancer’s severity, surpassing the 44% accuracy of lab analysis.
Capecitabine is an orally administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, that is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
JAK inhibitors which is a known class of medication, has for the first time been approved by the Food and Drugs Administration for the treatment of rare anemic patients with myelofibrosis. The drug works differently from similar medications by not causing a deficit of healthy red blood cells in patients.
Before you delve into this article, understand this crucial fact: colon cancer is preventable, treatable, and beatable. Waiting until symptoms arise is not the approach to take. Schedule your screening colonoscopy promptly. Screening for colon cancer in asymptomatic individuals is the means through which precancerous polyps are identified and removed, effectively preventing the onset of colon cancer. Colon cancer, also referred to as colorectal cancer, initiates in the large intestine, or colon. According to the Centers for Disease Control and Prevention (CDC), colon cancer ranks as the third most frequently diagnosed cancer in the United States, excluding skin cancer. It stands as the second primary cause of cancer-related deaths for both men and women combined.
The World Health Organization (WHO) has declared that the sweetener aspartame, commonly found in diet drinks and various food products, is a “possible carcinogen.” However, the WHO emphasizes that it remains safe for consumption in moderation and at already agreed-upon levels, according to reviews released by two groups linked to the organization.